Uncertainty about how US President-elect Donald Trump will apply tariffs has prompted an analyst at Toronto-Dominion Bank to ...

Fintel reports that on November 13, 2024, TD Cowen downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) from ...

Kronos Bio (KRON – Research Report) received a Hold rating and price target from TD Cowen analyst Tyler Van Buren yesterday. The ...

TD Cowen analyst Ken Cacciatore raised the firm’s price target on Biohaven (BHVN) to $75 from $55 and keeps a Buy rating on the shares. The firm said they expect Phase III data for T-alfa in SMA where ...

We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.33% of ...

Chris Krueger, MD, TD Cowen Washington Research Group, shares his thoughts on Trump’s policies when he takes office again in ...

Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...

TD Cowen on potential opportunities in Canadian equities. The potential impact of Canadian mortgage resets in 2025. Why demographic uncertainty could be a major challenge for the Canadian economy.

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...

Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...

TD Cowen analyst Brian Morrison downgraded Linamar Corp. to hold from buy, in part because “tariff uncertainty is bound to ...